{"id":"W3163768133","doi":"10.1021/acsmedchemlett.1c00127","title":"Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of <sup>11</sup>C-Labeled ALK2 Inhibitors","year":2021,"lang":"en","type":"article","venue":"ACS Medicinal Chemistry Letters","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Centre for Addiction and Mental Health","funders":"Azrieli Foundation; Canada Research Chairs; Ontario Institute for Cancer Research; Canada Foundation for Innovation; Ontario Research Foundation","keywords":"Neuroimaging; Positron emission tomography; Pons; Drug discovery; Radioligand; Medicine; Pet imaging; Activin receptor; Pharmacology; Neuroscience; Nuclear medicine; Bioinformatics; Receptor; Psychology; Internal medicine; Biology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252383,0.0002807688,0.0004940573,0.00008819711,0.0002495782,0.00006169758,0.0004790342,0.00003188187,0.00006762949],"category_scores_gemma":[0.0003528846,0.0002531248,0.00009299927,0.0004641287,0.0003316111,0.0001733172,0.0004364091,0.0001921692,0.000003582912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002743017,"about_ca_system_score_gemma":0.0008110522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005056614,"about_ca_topic_score_gemma":9.676355e-7,"domain_scores_codex":[0.9974775,0.00002033213,0.0005187001,0.0007138702,0.0007468616,0.000522686],"domain_scores_gemma":[0.9985242,0.0001987399,0.0001872085,0.0005081778,0.0002913567,0.0002902978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001362481,0.0004823306,0.0184524,0.0006273919,0.0001071803,0.001439181,0.002001592,0.00006715949,0.9673897,0.000004248524,0.006171091,0.003121454],"study_design_scores_gemma":[0.003819544,0.00005502141,0.004395845,0.0009659788,0.0002151498,0.0007389597,0.001757897,0.0003086177,0.9844737,0.000006697056,0.003037052,0.0002255208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805012,0.000387353,0.00004913829,0.01801792,0.0001098165,0.0004993898,0.000005298842,0.00003191194,0.0003979261],"genre_scores_gemma":[0.9921094,0.00001402144,0.004630703,0.002649017,0.000190448,0.0001292862,0.00009035535,0.00003497349,0.0001517521],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.017084,"threshold_uncertainty_score":0.9999921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02006528451640505,"score_gpt":0.2771546613823037,"score_spread":0.2570893768658987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}